Massive Transfusion Protocols: A Survey of Academic Medical Centers in the United States
Authors:
- 1 January 2017
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 124 (1) , 277-281
Abstract
BACKGROUND: Massive transfusion protocols (MTPs) have been adopted in many hospitals, and they may improve outcomes, as well as decrease the number of blood products transfused. However, there are no specific guidelines regarding the number and types of products that should be included in these protocols. MTPs may vary from hospital to hospital. METHODS: A short, web-based survey was sent to blood bank medical directors at academic institutions to learn details about MTPs. RESULTS: A total of 107 survey requests were sent, and 56 were completed (52% response rate). All who responded had an MTP in place. Nearly all (n = 55, 98.2% [95% CI, 90.6%–99.7%]) base their protocol on delivery of fixed amounts and ratios of blood products, with only a minority incorporating any elements of laboratory-directed therapy. The most common target, red blood cell (RBC):plasma ratio, is 1:1 (n = 39, 69.9% [95% CI, 56.7%–80.1%] of respondents). The majority (n = 36, 64.3% [95% CI, 51.2%–75.6%]) provide 6 or more units of red blood cells in the first MTP packet. CONCLUSIONS: One-hundred percent of survey respondents had an MTP in place. Despite a lack of published guidelines regarding MTPs, the survey results demonstrated substantial uniformity in numbers of products and target transfusion ratios.Keywords
This publication has 22 references indexed in Scilit:
- Massive Transfusion Protocols for Patients With Substantial HemorrhageTransfusion Medicine Reviews, 2011
- Blood product use in trauma resuscitation: plasma deficit versus plasma ratio as predictors of mortality in trauma (CME)Transfusion, 2011
- Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panelCritical Care, 2011
- Tranexamic acid for trauma – Authors' replyThe Lancet, 2010
- Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trialThe Lancet, 2010
- Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patientsTransfusion, 2010
- The Relationship of Blood Product Ratio to Mortality: Survival Benefit or Survival Bias?Journal of Trauma: Injury, Infection & Critical Care, 2009
- Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma PatientsAnnals of Surgery, 2008
- Black Hawk Down: The evolution of resuscitation strategies in massive traumatic hemorrhageCritical Care, 2008
- Massive Transfusion in Adults:Diagnoses, Survival and Blood Bank SupportVox Sanguinis, 1990